NO20040760L - Nye imidazopyridinforbindelser med terapeutisk virkning - Google Patents

Nye imidazopyridinforbindelser med terapeutisk virkning

Info

Publication number
NO20040760L
NO20040760L NO20040760A NO20040760A NO20040760L NO 20040760 L NO20040760 L NO 20040760L NO 20040760 A NO20040760 A NO 20040760A NO 20040760 A NO20040760 A NO 20040760A NO 20040760 L NO20040760 L NO 20040760L
Authority
NO
Norway
Prior art keywords
therapeutic effect
imidazopyridine compounds
new imidazopyridine
new
compounds
Prior art date
Application number
NO20040760A
Other languages
English (en)
Norwegian (no)
Inventor
Ingemar Starke
Kosrat Amin
Mikael Dahlstrom
Peter Nordberg
Original Assignee
Astrazeneca Ab Global Ip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip
Publication of NO20040760L publication Critical patent/NO20040760L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20040760A 2001-08-22 2004-02-20 Nye imidazopyridinforbindelser med terapeutisk virkning NO20040760L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102808A SE0102808D0 (sv) 2001-08-22 2001-08-22 New compounds
PCT/SE2002/001489 WO2003018582A1 (en) 2001-08-22 2002-08-21 Novel imidazopyridine compounds with therapeutic effect

Publications (1)

Publication Number Publication Date
NO20040760L true NO20040760L (no) 2004-02-20

Family

ID=20285105

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040760A NO20040760L (no) 2001-08-22 2004-02-20 Nye imidazopyridinforbindelser med terapeutisk virkning

Country Status (19)

Country Link
US (1) US20040220209A1 (https=)
EP (1) EP1421083A1 (https=)
JP (1) JP2005501870A (https=)
KR (1) KR20040036723A (https=)
CN (1) CN100343252C (https=)
AR (1) AR035465A1 (https=)
BR (1) BR0211846A (https=)
CA (1) CA2456350A1 (https=)
HU (1) HUP0401350A3 (https=)
IL (1) IL160143A0 (https=)
IS (1) IS7159A (https=)
MX (1) MXPA04001402A (https=)
NO (1) NO20040760L (https=)
NZ (1) NZ531110A (https=)
PL (1) PL367971A1 (https=)
RU (1) RU2294935C2 (https=)
SE (1) SE0102808D0 (https=)
WO (1) WO2003018582A1 (https=)
ZA (1) ZA200401114B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
KR20060099524A (ko) 2003-11-03 2006-09-19 아스트라제네카 아베 무증상 위식도 역류의 치료를 위한 이미다조[1,2-a]피리딘유도체
EP1711498A2 (en) * 2004-01-26 2006-10-18 Altana Pharma AG 1,2,4-triazolo¬1,5-a|pyridines as gastric acid secretion inhibitors
AU2005315303A1 (en) * 2004-12-17 2006-06-22 Pfizer Inc. Chromane derivatives useful as acid pump antagonists
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
EP1996589A1 (en) * 2006-03-17 2008-12-03 RaQualia Pharma Inc Chromane derivatives
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
KR200449743Y1 (ko) * 2008-03-11 2010-08-05 주식회사 보루네오가구 파티션용 상부 스크린의 고정구조
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
KR101605063B1 (ko) 2009-07-09 2016-03-21 라퀄리아 파마 인코포레이티드 소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제
PE20121438A1 (es) * 2009-09-24 2012-10-26 Hoffmann La Roche Derivados de imidazopiridina o imidazopirimidina como inhibidores de fosfodiesterasa 10a
FR2962437B1 (fr) 2010-07-06 2012-08-17 Sanofi Aventis Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique
DK3381917T3 (da) * 2013-01-31 2021-10-18 Bellus Health Cough Inc Imidazopyridinforbindelser og anvendelser deraf
MY169128A (en) * 2013-04-30 2019-02-18 Hoffmann La Roche Pd-catalyzed coupling of pyrazole amides
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
JP7578602B2 (ja) 2019-02-25 2024-11-06 グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー3)、リミテッド P2x3修飾薬での治療

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UA48122C2 (uk) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
WO1996003405A1 (de) * 1994-07-28 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridin-azolidinone
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
MXPA04001402A (es) 2004-05-27
JP2005501870A (ja) 2005-01-20
ZA200401114B (en) 2005-06-22
EP1421083A1 (en) 2004-05-26
NZ531110A (en) 2005-10-28
PL367971A1 (en) 2005-03-07
AR035465A1 (es) 2004-05-26
BR0211846A (pt) 2004-09-08
IL160143A0 (en) 2004-06-20
CN1543464A (zh) 2004-11-03
WO2003018582A1 (en) 2003-03-06
SE0102808D0 (sv) 2001-08-22
CN100343252C (zh) 2007-10-17
IS7159A (is) 2004-02-20
RU2294935C2 (ru) 2007-03-10
US20040220209A1 (en) 2004-11-04
HUP0401350A3 (en) 2009-03-02
KR20040036723A (ko) 2004-04-30
HUP0401350A2 (hu) 2004-12-28
CA2456350A1 (en) 2003-03-06
RU2004103628A (ru) 2005-06-27

Similar Documents

Publication Publication Date Title
DE60308332D1 (de) Chinazolinverbindungen mit therapeutischem nutzen
NO20052914D0 (no) Terapeutiske forbindelser
NO20042140L (no) Terapeutiske quionolonforbindelser med 5-HT anatagonistiske egenskaper
NO20033203D0 (no) Terapeutiske heterocykliske forbindelser
NO20042154L (no) Terapeutiske isokinolinforbindelser
NO20035428D0 (no) Nye anti-ineffektiver
NO20034992D0 (no) Nye 4-aninlinokinolin-3-karboksamider
CY2014018I2 (el) Kαρβαμιδο - υποκατεστημενες πυραζολοπυριδινες
DE60315135D1 (de) Therapiesonde
DE60319951D1 (de) Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
NO20034970D0 (no) Nye arylheteroalkylaminderivater
NO20040760L (no) Nye imidazopyridinforbindelser med terapeutisk virkning
NO20033205L (no) Terapeutiske kromanforbindelser
EE200200568A (et) Ravis kasutatavad difenüüleetriühendid
DK1597171T3 (da) Terapeutisk mikroskum
NO20050689L (no) Terapeutisk anvendelse
NO20035248D0 (no) Nye fenylalkyloksy-fenyl derivater
NO20025902D0 (no) Nye fenylpiperaziner
DK1641793T3 (da) Hidtil ukendt imidazopyridinforbindelse II med terpeutisk effekt
SE0100006D0 (sv) Therapeutic compounds
SE0100007D0 (sv) Therapeutic compounds
SE0100008D0 (sv) Therapeutic compounds
SE0100009D0 (sv) Therapeutic compounds
SE0203451D0 (sv) Therapeutic Heterocycles
SE0203450D0 (sv) Therapeutic heterocycles

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application